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Background: The TIR domain-containing proteins BtpA/Btp1/TcpB and BtpB are translocated into host cells by the
facultative intracellular bacterial pathogen Brucella. Here, they interfere with Toll like receptor signalling to temper
the host inflammatory response. BtpA has also been found to modulate microtubule dynamics. In both proteins we
identified a WxxxE motif, previously shown to be an essential structural component in a family of bacterial type III
secretion system effectors that modulate host actin dynamics by functioning as guanine nucleotide exchange factors
of host GTPases. We analysed a role for the WxxxE motif in association of BtpA and BtpB with the cytoskeleton.
Results: Unlike BtpA, ectopically expressed BtpB did not show a tubular localisation, but was found ubiquitously in the
cytoplasm and the nucleus, and often appeared in discrete punctae in HeLa cells. BtpB was able to protect
microtubules from drug-induced destabilisation similar to BtpA. The WxxxE motif was important for the ability of BtpA
and BtpB to protect microtubules against destabilising drugs. Surprisingly, ectopic expression of BtpA, although not
BtpB, in HeLa cells induced the formation of filopodia. This process was invariably dependent of the WxxxE motif. Our
recent resolution of the crystal structure of the BtpA TIR domain reveals that the motif positions a glycine residue that
has previously been shown to be essential for interaction of BtpA with microtubules.
Conclusions: Our results suggest a structural role for the WxxxE motif in the association of BtpA and BtpB with
microtubules, as with the WxxxE GEF family proteins where the motif positions an adjacent catalytic loop important for
interaction with specific Rho GTPases. In addition, the ability of ectopically expressed BtpA to induce filopodia in a
WxxxE-dependent manner suggests a novel property for BtpA. A conserved WxxxE motif is found in most bacterial and
several eukaryotic TIR domain proteins. Despite the similarity between ectopically expressed BtpA and WxxxE GEFs to
modulate host actin dynamics, our results suggest that BtpA is not part of this WxxxE GEF family. The WxxxE motif may
therefore be a more common structural motif than thus far described. BtpA may provide clues to cross-talk between
the TLR and GTPase signalling pathways.
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Brucella is a Gram negative facultative intracellular bac-
terium that can cause brucellosis or Malta Fever, the
world’s most widespread zoonotic disease [1]. In humans
Brucella causes an undulant fever that can be accom-
panied by complications such as endocarditis, arthritis
and osteomyelitis [2]. Brucella is a stealth pathogen,
known for its silent entry into host cells and multiple
mechanisms to suppress host innate immune signalling,
including non-toxic lipid A, and avoidance of oxidative
burst and Toll like receptor (TLR) signalling cascades
[2-6]. Whereas the primary task of immune cells is to
phagocytose and degrade microbes, many intracellular
pathogens, including Brucella, use secretion systems to
introduce bacterial effector proteins directly into host
cells to alter host cell biology and favour their intracellu-
lar replication [7,8]. For full virulence, Brucella requires
its VirB type IV secretion system (T4SS) to modulate
endosomal trafficking, and create a replication niche in
ER-derived membrane vesicles, named Brucella con-
taining vacuoles (BCV) [9-11]. For many years, the ef-
fector proteins translocated by the Brucella VirB system
remained elusive. After the identification of a first can-
didate [12], recent efforts from several laboratories,
using both bioinformatics screens and translocation as-
says have resulted in a list of possible effectors [13-16].
To date, the precise role of most of these proteins in
Brucella virulence is still not clear and the subject of in-
tense research.
Recently, the proteins BtpA (Btp1/TcpB) and BtpB
have been shown to be translocated by Brucella into
host cells [17]. Although a TEM-1 β-lactamase assay did
not show a significant difference in translocation effi-
ciency of the proteins from wild type and virB mutant
bacteria, a CyA reporter assay showed VirB-dependent
protein transport into host cells, suggesting BtpA and
BtpB may be substrates of the VirB T4SS. BtpA and
BtpB belong to a class of bacterial proteins first de-
scribed in Salmonella, Escherichia coli and Brucella that
share homology with the eukaryotic Toll/Interleukin-1
receptor (TIR) domain [18,19]. A conserved TIR domain
is present in eukaryotic TLR proteins as well as their
downstream signalling TIR adaptor proteins, including
the central cytosolic adapter protein MyD88. The TIR
domain is essential for TLR and adaptor interactions
and for the onset of a signalling cascade resulting in nu-
clear translocation of the transcription factor NFκB,
followed by the production of pro-inflammatory cyto-
kines and type I interferons [20]. TIR domain interac-
tions play a key role in activating conserved cellular
signal transduction pathways in response to pathogen
signals, and it was suggested that bacterial TIR proteins
interfere with host TLR defence signalling by molecular
mimicry (reviewed in [21]).B. abortus 2308 BtpA (BAB1_0279) and the almost
identical B. melitensis 16M BtpA (BMEI1674) down
modulate maturation of dendritic cells [22] and inhibit
TLR-induced NFκB activation. It has been suggested
that this is through interference with the TLR4/MyD88/
TIRAP complex [23-27], however the exact binding partner
of BtpA is still a subject of controversy. Far less is known
about BtpB, however recently it has also been shown to
play a role in immune modulation [17]. Recently we,
and others, published the crystal structure of the BtpA
TIR domain, which showed a dimeric arrangement of a
canonical TIR domain [25,28,29], but significant differ-
ences in loop structures suggest that these proteins
could interfere with intrinsic host TLR signalling path-
ways. These recent advances will help to more precisely
determine the exact molecular mechanisms of this mo-
lecular mimicry, and to further address the different
roles these proteins may play in virulence.
In addition to an important role for BtpA and BtpB
in inhibiting TLR-mediated immune responses, in vitro
and overexpression studies have shown that BtpA tightly
interacts with microtubules and is able to stabilize polymer-
ized microtubules by inhibiting microtubule disassembly
induced by the microtubule-drug nocodazole [30]. Here
we show that BtpB, in addition to BtpA, is also able to
protect microtubules from drug-induced depolymerization.
We have identified a WxxxE motif in BtpA and BtpB.
A conserved WxxxE motif has been shown to have a
structural role in a family of T3SS effectors, which
transiently subvert host actin dynamics by functioning
as Guanine nucleotide Exchange Factors (GEFs) of Rho
GTPases [31,32]. We provide evidence that the WxxxE
motif in BtpA and BtpB is an important structural deter-
minant for protection of microtubules suggesting a func-
tional association with microtubules for both proteins. In
addition, we show that ectopically expressed BtpA induces
the formation of filopodia in a WxxxE-dependent manner.
Our results are supported by the crystal structure of BtpA.
Results
A conserved WxxxE motif in BtpA organizes functional
surface loops
BtpA and BtpB have both been shown to have immune
modulatory functions in the host cell through their TIR
domains by directly interfering with TLR signalling [17],
supported by recent structural information [25,28,29].
btpA and btpB are located on different genomic islands
[33]. We analysed 407 genomes in the PATRIC database
(http://patricbrc.vbi.vt.edu/portal/portal/patric/Home,
January 2014). Whereas the GI carrying btpB is found
in the genomes of all the classical Brucella strains,
the GI containing btpA shows variable distribution
(Additional file 1: Figure S1). The btpA and btpB genes
show 11% amino acid identity, and are highly conserved
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domain, we found that BtpA and BtpB contain a WxxxE
motif (Figure 1) (except in all B. melitensis which have the
Trp residue changed into Arg in BtpB). A conserved
WxxxE structural motif has been described to be important
in a family of bacterial type III secretion system effectors,
including Shigella IpgB1 and enteropathogenic Escherichia
coli Map (Figure 2A), for their function as guanine nucleo-
tide exchange (GEF) mimics for Rho GTPases [31,34].
A large family of TIR proteins in both pathogenic and
non-pathogenic bacteria has recently been described
[21,35]. Interestingly, sequence alignment shows that the
WxxxE motif is highly conserved among the bacterial
TIR proteins, including Paracoccus denitrificans PdTir,
Yersinia pestis YpTdp, Salmonella enterica TlpA, and
Escherichia coli TcpC (Figures 1B, 2A) and eukaryotic
TLR proteins (TLR1, 2, 4, 6 and 10). Although the motif
is not conserved in the TIR adaptor proteins TIRAP/
Mal, TRAM, MyD88 and TRIF, it is present in SARM
(Figure 1B), the only TIR adaptor protein that has been
shown to negatively regulate TLR signalling [36]. The
conservation of the WxxxE motif in a large number of
TIR domain proteins suggests the WxxxE motif could
have an important structural role, as shown for the WxxxE
GEF family proteins.
In the bacterial GEF proteins, the WxxxE motif has
been shown to be instrumental in positioning the so-
called catalytic loop that participates in the interaction
with GTPases such as Cdc42 or Rac [37] (Figure 2A). In
the BtpA structure, the WxxxE motif is located in the
αC helix (Figure 1B) and interacts with the C-terminal
part of the BB loop (Figure 2B). The nitrogen of the
tryptophan ring interacts with the hydroxyl group of the
D184 main chain while the side chain of E217 interacts
with the S185 (Figure 2B). This organization is reminis-
cent of the WxxxE bonding with the SS motif of the
catalytic loop in the EPEC Map effector ([34], Figure 2B).
In BtpA, however, this interaction positions a glycine
residue (G183) in close proximity to the WxxxE pocket
(Figure 2B). Interestingly, G183 has been shown to be
important for interaction of BtpA with microtubules
(G158 in [23,24]). Other than the WxxxE motif, no sig-
nificant structural sequence similarity is present between
known WxxxE family GEFs and BtpA. It is of note that
the Brucella BtpB protein does not have the G residue at
the corresponding position.
Despite the high degree of conservation of the WxxxE
motif in the family of bacterial and eukaryotic TIR
proteins, structural comparison between the available
structures indicates that the interaction between the
WxxxE motif and the D residue in the BB loop only
occurs in BtpA and PdTIR, and not any of the eukaryotic
TIR proteins (Figure 2C). In TLR2 for instance, the WxxxE
packs against the DD loop and αD helix (Figure 2C).Together, these observations indicate that a conserved
WxxxE motif may be an important structural component
in a family of bacterial TIR proteins by positioning differ-
ent loop structures. More specifically, in BtpA the WxxxE
motif may play a structural role by positioning the G183
residue for interaction with microtubules.
The WxxxE motif is important for subcellular localisation
of BtpA and protection of microtubules
Besides its important role in interference with TLR sig-
nalling BtpA has been shown to modulate microtubule
dynamics and protect microtubules from drug-induced
depolymerisation [30]. To address a possible role for the
WxxxE motif in interaction of BtpA with microtubules,
we performed ectopic expression analysis to study the
subcellular localisation of the wild type protein and a
panel of variants. We created N-terminal fusions of BtpA
to GFP in a eukaryotic expression plasmid, and transfected
HeLa cells. Confocal and fluorescence microscopy showed
that GFP-BtpA formed a filamentous network in the cell
(Additional file 2: Figure S2, and Figure 3C, and [24]).
In contrast to Radhakrishnan et al. [24], we did not
find any evidence for rounding up or shrinkage of cells.
Importantly, localisation of BtpA was similar when
expressed without the GFP tag and detected with anti-
BtpA antibodies (data not shown).
GFP-BtpA predominantly colocalised with microtubules,
labelled with anti-β-tubulin antibodies (Additional file 3:
Figure S3, and [24]). Confocal imaging clearly showed that
the BtpA tubules localised at the periphery of the cell and,
although not colocalising along the complete microtubule
network, they showed a regular interaction with the cyto-
skeleton. Similar to observations reported by Radhakrishnan
and colleagues, BtpA could prevent the microtubule desta-
bilizing effect of nocodazole (Figure 3C, D).
Next, we analysed the subcellular localisation of different
GFP-BtpA WxxxE variants and their effect on microtubule
destabilisation by nocodazole. Using site-directed mutagen-
esis with the GFP-BtpA expression plasmid as a template,
the substitutions W213A, W213F, W213S, E217D, E217A,
as well as I226S, and G183A were introduced. Despite very
low amino acid sequence homology between BtpA and
BtpB, and members of the WxxxE GEF family, we identi-
fied a conserved isoleucine residue, 9 amino acids down-
stream of the WxxxE motif and included a variant in our
study. Subcellular localisation of the GFP-fusion proteins
was confirmed using BtpA antibodies (data not shown). The
different GFP-BtpA variants were ectopically expressed in
HeLa cells and details are presented in Table 1 and Figure 3.
Although the W213A variant behaved as wild type BtpA,
both in subcellular localisation as well as its ability to pre-
vent microtubule destabilisation (Figure 3E, F), substitution
of W213 with F or S resulted in a diffuse GFP signal in the
cell, indicating these changes greatly affected the localisation
Figure 1 (See legend on next page.)
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Figure 1 Btp protein structure, and sequence alignment indicating TIR domains and position of WxxxE motif. (A) Schematic representation of
the Brucella BtpA and BtpB proteins with the position of TIR domain boxes and WxxxE motif indicated. (B) Multiple sequence alignment of Brucella
melitensis BtpA (AAL52855.1), Brucella suis BtpB (AAN29664.1), Paracoccus denitrificans PdTir (3H16_D), Salmonella enterica TlpA (WP_000116933.1), Escherichia
coli TcpC (ADO30450), Yersinia pestis YpTdp (NP_669733.1), human TLR1 (AAY85643.1), human TLR2 (AGR82491.1), human TLR4 (AAY82267.1), human TLR10
(AAY78485.1), SARM (AAH40429.1), Mal/TIRAP (AF406652_1), TRIF (AAH09860), TRAM (NP_067681), MyD88 (AAB49967.1). The alignment shows the
sequence encompassing the TIR domain boxes 1 and 2, and WxxxE motif. The alignment was performed with T-coffee analysis, and edited using Jalview,
using the ClustalX colour scheme. Structural features indicated above the sequence alignment according to Kaplan-Türköz [28]. The residues mutated in
this study are indicated with red (W213, E217, and G183) and black (I226) dots.
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correlated with the inability of these variant proteins
to protect microtubules from degradation by nocodazole
(Figure 3G-J); interestingly, in 1.9% of the transfected cells
the W213F variant localised in a tubular structure and,
in these cells, was able to prevent degradation of micro-
tubules, showing the substitution did not affect the abil-
ity of the W213F variant to protect microtubules from
depolymerisation when localised correctly.
The E217A variant, however, was still found in tubular
structures in approximately 53% of the transfected cells
yet, in contrast to the W213A and W213F variants, was
unable to prevent degradation of microtubules by noco-
dazole even in those cells (Figure 3K, L). Interestingly, a
conservative substitution resulting in the E217D variant,
greatly affected GFP-BtpA localisation (Table 1), but
again, in about 1% of the transfected cells the E217D
variant localised in a tubular structure and in these
cells was able to prevent degradation of microtubules.
These results demonstrate that the Glu residue is also
important for localisation of GFP-BtpA, and suggest
in addition that negative charge at this position isFigure 2 Conservation of the WxxxE motif. (A). Sequence alignment of
TIR proteins BtpA, BtpB, PdTir, TcpC and TlpA; and eukaryotic hTLR2, hTIRAP
(slate) structure depicted as ribbons and highlighting the residues W and E
ball and sticks for the residues involved in the structural scaffold (see text f
shown as red balls and sticks) and BB loop (blue) organisation in the structessential for the ability of BtpA to protect microtubules
from degradation.
The G183 residue lays adjacent to the WxxxE motif in
the BtpA crystal structure (Figure 2B). The G183A
variant behaved as reported earlier [24] and was unable
to colocalise with microtubules, and expectedly unable
to prevent microtubule degradation (not shown). The
I226S variant formed a tubular network in about 14%
of the cells (Table 1), and was able to prevent micro-
tubule degradation in these cells (Figure 3M), showing
that this residue is not critical for the ability of BtpA to
protect microtubules. Together, our results show that the
WxxxE motif is important for both subcellular localisation
of BtpA and its ability to protect microtubules from
nocodazole-induced depolymerisation.
BtpB protects microtubules from degradation in a
WxxxE-dependent manner
Although a role for BtpB in modulation of TLR signalling
has been reported recently [17], it is not known whether
BtpB associates with microtubules in a manner similar to
BtpA. First, we performed ectopic expression analysis tothe WxxxE containing T3SS effectors Map, IpgB1 and SifA; the bacterial
and hMyD88. (B). Structural comparison of Map (yellow) and BtpA
(purple), and catalytic and BB loops (blue). Side chains are shown in
or details). (C). Comparison of the WxxxE motif (with W and E residues
ures of PdTir (gold), TLR2 (green) and TIRAP (wheat).
Figure 3 Interaction with and stabilization of microtubules by BtpA against Nocodazole-induced depolymerization is WxxxE-dependent.
HeLa cells were transfected with plasmids expressing GFP-BtpA (C, D), GFP-BtpA WxxxE variants (E-L), or I226S (M), respectively. Sixteen hours after
transfection cells were either left untreated (A, C, E, G, I, K) or treated with 1 μg/ml nocodazole for 30 min (B, D, F, H, J, L, M). Nocodazole-treated
and control cells were fixed and stained with mouse anti β-tubulin antibody, followed by detection with anti-mouse Texas Red, and analysed
by fluorescence microscopy. (A) Fluorescent image of tubulin-stained non-transfected control cells (B) Fluorescent image of non-transfected,
nocodazole-treated cells. (C-M) Individual green and red fluorescent images and overlay image of HeLa cells expressing (C-D) GFP-BtpA,
(E-F) GFP-BtpA W213A, (G-H) GFP-BtpA W213S, (I-J) GFP-BtpA W213F, (K-L) GFP-BtpA E217A, (M) GFP-BtpA I226S. Arrow heads indicate
individual cells showing inhibition of nocodazole-induced microtubule depolymerization by expression of (D) GFP-BtpA, (F) GFP-BtpA W213A,
and (M) and I226S, in contrast to non-transfected cells. Arrows indicate nocodazole-induced microtubule depolymerization in individual cells
expressing (H) GFP-BtpA W213S, (J) GFP-BtpA W213F, (L) GFP-BtpA E217A. Scale bar, 25 μm indicated in A applies to all individual green and
red fluorescent images. The overlay images are close ups of individual cells in the corresponding red and green fluorescent images. Data are
representative of 3 or more independent experiments.
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an N-terminal fusion of BtpB to GFP in a eukaryotic
expression plasmid, and transfected HeLa cells. Using
confocal and fluorescence microscopy we observed that,
unlike BtpA, GFP-BtpB did not localise in filaments, but
was found ubiquitously in the cytoplasm and the nucleus
(Figures 4A-D, 5A), with an expression pattern varying
from a diffuse GFP signal in about 50% of cells to cells
which additionally showed accumulation of GFP-BtpB in
one or more discrete punctae (Additional file 4: Figure S4).
These discrete structures were heterogeneous in size and
detected in the cytoplasm as well as the nucleus (Figure 4B).
Surprisingly, in microtubule protection assays we found thatBtpB was, like BtpA, able to prevent microtubules from
depolymerisation by nocodazole (Figures 4E, F; 5B),
suggesting that BtpB might be a microtubule-associated
protein with a strong microtubule stabilizing property.
Analysis of the number of transfected cells showing
either complete or no protection indicated that 63.4%
(±7.55, n = 110, 2 independent experiments, Table 1)
showed protection of the microtubule network from
depolymerisation. Full protection from nocodazole-induced
destabilisation was found in a higher percentage of cells
showing (at least one) BtpB puncta (82.2%), compared
to protection found in cells with a diffuse BtpB signal
only (24.5%) (see Table 1). This suggests that, although
Table 1 Influence of mutations in the WxxxE motif of BtpA and BtpB on subcellular localisation, microtubule-protection
and filopodia induction
BtpA or variant Localisation of GFP-BtpA in filaments
(% of transfected cells ± SD)
Protection of microtubules after
NC treatment (% of cells with
BtpA arranged in filaments)a
Induction of filopodia
(% of cells with BtpA
arranged in filaments)b
BtpA 90.5 ± 1.36 73,8 ± 3.45 75.9 ± 0.26
BtpA W213S 0 0 0
BtpA W213A 90.1 ± 3.86 75,6 ± 5,00 0
BtpA W213F 81.9 ± 1.81 87,1 ± 5,36 0
BtpA E217D 1.3 ± 0.78 83.9 ± 9.89 0
BtpA E217A 52.6 ± 6.67 0 0
BtpA I226S 14.4 ± 1.93 76,1 ± 3,66 69.7 ± 3.5
BtpA G183A 0 0 0
BtpB or variant Protection of microtubules after NC treatment (% of cells with)c Induction of filopodia
Diffuse BtpB pattern Punctate BtpB pattern
BtpB 24.5 ± 0.71 82,2 ± 1.59 0
BtpB W263S 0 0 0
BtpB E267A 0 0 0
HeLa cells were transfected with plasmid DNA harbouring pCMV:GFP-BtpA, pCMV:GFP-BtpB or the respective Btp variants. After 16–20 hours cells were left
untreated or treated with 1 μg/ml nocodazole for 30 min and fixed. Microtubules were visualised using β-tubulin antibodies and detected with Texas-Red
conjugated secondary antibodies. For localisation studies, at least 200 transfected cells were analysed per variant per experiment. Data are given in average
percentage of transfected cells ± SD (of three independent experiments per variant). For analysis of filopodia, cells were fixed 16-20h hours after transfection, and
actin detected with Rhodamine Phalloidin. Each variant was analysed in at least 3 independent experiments.
aFor wildtype BtpA and variants, protection of nocodazole-induced microtubule destabilisation was observed only in transfected cells showing BtpA in filaments.
Indicated is the average percentage of cells with filaments that show protection, calculated from two individual experiments (±SD). Cells that showed partial
protection were not taken into consideration. At least 100 cells per experiment were counted for BtpA wildtype, BtpA W213A, and BtpAI226S. For BtpA W213F
and BtpA E217D, seen the low percentage of transfected cells with BtpA localising in filaments, about 12 cells with BtpA organised in filaments were counted in 2
independent experiments. BtpA W213S, BtpAE217A and BtpAG183A did not show any protection.
bWildtype BtpA and the I226S variant showed induction of filopodia only in transfected cells showing BtpA in filaments. Counts are based on a total of 67 cells
with BtpA in filaments in each of 2 independent experiments.
cBtpB transfected cells showed a large variation in ectopic expression phenotypes: Low GFP expression, high GFP expression, and with or without punctae
(varying from 1 to over 50). As for BtpA, cells showing partial protection were not taken into account. In two independent experiments 62 and 48 cells (of which
32.7% ± 10.8 were cells without punctae), respectively were analysed for protection of microtubules.
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discrete sites correlated with better protection of micro-
tubules after nocodazole treatment.
The ability of BtpB to protect microtubules from
degradation suggests that, like BtpA, BtpB might somehow
associate with microtubules. Further inspection of confocal
slices showed that cytoplasmic BtpB punctae showed partial
colocalisation with β-tubulin (Figure 4B-D). In addition,
our microscopic studies gave some further interesting
observations. We often found GFP-BtpB foci at the
microtubule-organizing centre (MTOC) (Figure 4C).
Intriguingly, we observed that BtpB localised at a discrete
ring structure in the intercellular bridge between divid-
ing cells during late stages of cytokinesis and abscission,
even in cells that had been treated with nocodazole
(example shown in Figure 4E, Additional file 5: Figure S5B).
Accumulated GFP-BtpB was still detected in post-mitotic
midbodies (MB), associated with one of the two daughter
cells after abscission, probably still connected through the
thin stalk connected to the daughter cell [38].
Colocalisation studies with conjugated ubiquitin, using
MAb FK2 that detects mono- and poly ubiquinatedproteins, showed almost perfect colocalisation of GFP-BtpB
punctae with conjugated ubiquitin, both in the cytoplasm
and the nucleus. They also showed that the GFP-BtpB ring
structure observed between dividing cells perfectly coloca-
lised with FK2, demonstrating GFP-BtpB accumulates at
the single, circular structure with densely ubiquitinated pro-
teins that has been described to form in the midbody of the
intercellular bridge [39] (Additional file 5: Figure S5A,B).
Punctae with accumulated conjugated ubiquitin were also
readily detectable in non-transfected cells (Additional file 5:
Figure S5C), suggesting that in our cell transfection as-
says the local accumulation of conjugated ubiquitin is
not dependent on BtpB overexpression. Together with
the different observed subcellular localisation, these
preliminary data suggest that BtpB is recruited to sites
with high concentrations of ubiquitinated proteins,
also during cytokinesis.
In line with our studies with BtpA, we further analysed
the subcellular localisation of two GFP-BtpB WxxxE
variants and their effect on the microtubule destabilising
effects of nocodazole. Using site-directed mutagenesis, the
substitutions W263S and E267A were introduced in the
Figure 4 (See legend on next page.)
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Figure 4 BtpB subcellular localisation. HeLa cells were transiently transfected with a plasmid encoding GFP-BtpB. Sixteen hours after transfection,
cells were left untreated (A-D), or treated (E, F) with 1 μg/ml nocodazole for 30 min, fixed and stained with mouse anti β-tubulin antibody, followed
by detection with anti-mouse Texas Red. (A). Confocal images of BtpB and the microtubule network. From left to right, merged stack images of 8 Z-slices
of overlay, and individual GFP-BtpB (green) and tubulin (red) images are shown. Scale bar 10 μm. (B). Images, from left to right, show the individual Z-slices
(0,3 μm depth) from the cell presented in A. The arrow head in panel 4 indicates GFP-BtpB accumulation in the nucleus. Boxed areas in panels 4
and 6 are shown enlarged in C and D. (C) Individual image (red filter) showing microtubule network at the MTOC (the lines indicate the area of
GFP-BtpB colocalisation, as shown in the overlay image below). (D) Partial association of BtpB punctae and tubulin indicated with arrows. Enlargement
(10x). (E) and (F) Confocal slices of HeLa cells after nocodazole treatment (+NC). Arrows indicate individual cells showing complete protection of
nocodazole-induced microtubule depolymerization in transfected cells. Boxed areas are shown enlarged. Scale bar 10 μm. (E) Arrow head in enlarged
image points at GFP-BtpB accumulation in the Midbody of the intercellular bridge.
Felix et al. Cell Communication and Signaling 2014, 12:53 Page 9 of 15
http://www.biosignaling.com/content/12/1/53GFP-BtpB expression plasmid. Ectopic expression in HeLa
cells often resulted in larger punctae than found for BtpB
(Figure 5C, E). Treatment with nocodazole resulted in the
formation of even larger GFP-BtpB aggregates than in
non-treated cells, and these variant proteins were not
able to stabilize microtubules (Figure 5D, F). These
data show that also for BtpB the WxxxE motif is im-
portant for protection of microtubules.
Ectopic expression of BtpA induces formation of filopodia in
a manner that is invariably dependent of the WxxxE motif
Despite low sequence conservation with proteins belonging
to the family of bacterial WxxxE GEFs that modulate host
actin dynamics, we were interested in a possible link of the
Btp proteins with the actin network. Although we could
not visually detect colocalisation with actin filaments in the
cell for BtpA and BtpB, we detected actin rich cytoplasmic
projections in HeLa cells expressing BtpA, but not BtpB,
that we identified as filopodia (Figure 6). Distinctive
filopodia that extend beyond the cell boundary were
observed only in cells expressing GFP-BtpA, but not in
non-transfected cells or the GFP control. We analysedFigure 5 WxxxE-dependent protection of microtubule from nocodazo
transfected with plasmids encoding GFP-BtpB (A-B), GFP-Btp W263S (C, D)
left untreated (A, C, E), or treated (B, D, F) with 1 μg/ml nocodazole for 30
by detection with anti-mouse Texas Red. (A-F) Individual green and red flu
representative of 3 or more independent experiments.the effect of ectopic expression of our panel of BtpA
variants on the formation of filopodia. Interestingly,
substitution of the conserved W and E residues, as well
as G183, disrupted the ability of BtpA to induce filo-
podia; in contrast, the I226S variant was able to induce
the formation of these actin filament bundles showing
this residue is not critical for this (Table 1). These re-
sults clearly demonstrate that the conserved W213 and
E217 residues are critical for the induction of filopodia
in transfected HeLa cells by BtpA.
Discussion
Intracellular bacterial pathogens employ secretion sys-
tems to introduce bacterial effectors directly into cells,
where these proteins interfere with host cell biology and
immune defences allowing the pathogen to survive and
build an intracellular niche favourable to replication.
Effectors from different pathogens have been shown to
target many common cellular functions, including cyto-
skeleton dynamics, immune functions, GTPase signalling,
host gene transcription, and ubiquitination. The stealth
pathogen Brucella is famous for its silent entry into thele-induced depolymerisation by BtpB. HeLa cells were transiently
, or GFP-BtpB E267A (E, F). Sixteen hours after transfection, cells were
min, fixed and stained with mouse anti β-tubulin antibody, followed
orescence and overlay images of HeLa cells. Scale bar, 25 μm. Data are
Figure 6 Ectopic expression of BtpA in HeLa cells induces
filopodia. HeLa cells were transiently transfected with plasmids
encoding GFP-BtpA. Sixteen hours after transfection the cells were
fixed and actin was stained with Rhodamine phalloidin. Images
were taken using confocal fluorescence microscopy. Large image
on top, Z-Stack of 16 merged images slices (1 μm depth) of HeLa
cells, showing actin distribution (red) and one cell expressing
GFP-BtpA (green). The smaller images below are individual image
slices. Scale bar, 25 μm. Data are representative of 3 or more
independent experiments.
Felix et al. Cell Communication and Signaling 2014, 12:53 Page 10 of 15
http://www.biosignaling.com/content/12/1/53host and avoidance of phagolysosomal degradation, and
the translocated proteins BtpA and BtpB have been shown
to contribute to this strategy by targeting the host’s
TLR-dependent arm of the innate immune defence
[40]. Although studies are hampered by the lack of an
attenuated virulence phenotype in cell culture systems
(reviewed in [9]), recently Salcedo et al., using wild type
mice, suggested that BtpA and BtpB contribute to virulence
and control of local inflammatory responses [17].
The molecular mechanisms by which BtpA interferes
with TLR4 and TLR2 signalling pathways remain contro-
versial, due to the inconsistency between reports describ-
ing interaction with the adaptor proteins MyD88 and/or
TIRAP/MAL [19,24,26,27,41]. Recent structural studies
are now complementing biochemical, in vitro and over-
expression studies, and the picture starts to emerge that
BtpA may inhibit downstream MyD88-dependent signal-
ling by competing with TIRAP in binding to the TLR4 re-
ceptor protein [25,28,29]. This process has been suggested
to take place at the plasma membrane, possibly through a
phosphoinositide interaction module with which BtpA in-
serts itself in the membrane [23-25]. However, the situation
seems more complex, as BtpA has also been shown to be
involved in microtubule dynamics and, very recently, in the
induction of the unfolded protein response [30,42].
Our data corroborated previous reports showing that
BtpA interacts with microtubules in vitro [30], and that
ectopically expressed BtpA formed a filamentous network
in HeLa cells that partially colocalised with microtubules
[24]. We found that this association was essential to block
drug-induced depolymerisation of microtubules.
The second Brucella TIR protein, BtpB, has only recently
been demonstrated to play a role in interference with
TLR signalling [17], and the molecular mechanism of
interference is as yet unknown. We were interested to
find out whether BtpB is able to associate with the
microtubule network. Here, we provide evidence that
ectopically expressed BtpB equally protects microtu-
bules from nocodazole-induced degradation in a WxxxE
dependent manner. This result places BtpB at the interface
of the microtubule network and TLR signalling, similar
to BtpA. We observed partial colocalisation of visible
BtpB punctae with β-tubulin in confocal slices, and the
presence of BtpB punctae was correlated with better
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results further showed that BtpB colocalises with sites
of accumulated ubiquitinated proteins, which were equally
observed in non-transfected cells, not only in the cyto-
plasm but also in the nucleus and at a discrete region in
the central spindle region between dividing cells, to which
cytokinetic proteins are recruited to promote cell division.
The central spindle is a bundle with interdigitated anti-
parallel microtubules between separating chromosomes.
The FK2-positive Midbody ring has been shown to be a
dynamic site of ubiquitination during the important
later stages of cell division and abscission, when the
cells finally detach [39]. More experiments are needed
to determine if it is an association with microtubules
or the UPS that causes the accumulation of ectopically
expressed GFP-BtpB at the Midbody ring during cell
division. Although colocalisation of BtpB punctae with
conjugated ubiquitin raises the question as to whether
BtpB itself could be sequestered by one of the cellular
host mechanisms that deals with misfolded proteins
[43-45], our preliminary observations provide an indi-
cation for a functional link of BtpB, microtubules and
the Ubiquitin Proteasome system (UPS). Many viral and
bacterial proteins have been shown to interfere with host
ubiquitination processes [46,47], and further experiments
should provide more information whether BtpB could for
instance enhance poly ubiquitination of TIR proteins,
similar as shown for BtpA which targets the TIR adaptor
TIRAP for degradation by polyubiquination [27].
Modulation of the host cytoskeleton by bacterial
virulence factors is a common microbial strategy used
by many pathogens at different stages of the infection
process (reviewed in [48]. The actin network is often
modulated by bacterial proteins that target the host
small GTPases that are the essential signalling inter-
mediates in actin dynamics [49]. During our studies we
found that, besides colocalising with microtubules, ec-
topically expressed BtpA, but not BtpB, also induced
actin rich filopodial protrusions in HeLa cells, a mainly
Cdc42-dependent process. A WxxxE motif, that we
identified in BtpA and BtpB led us to hypothesise that
BtpA may induce GTPase activation in a similar man-
ner as proteins belonging to the family of WxxxE/SopE
T3SS effectors, most of which have been demonstrated
to be Rho-GEFs. Ectopic expression of these WxxxE
effectors has been shown to result in WxxxE-dependent
formation of filopodia, stress fibers or lamellipodia,
phenotypes that are typically associated with selective
activation of the Rho GTPases Cdc42, RhoA and Rac1,
respectively [34,50]. Our expression studies in HeLa
cells revealed that conservation of the W and E residues
was crucial for the ability of BtpA to induce actin rear-
rangements, similar to the WxxxE GEF family effec-
tors [32,51,52]. Although BtpA did not show sequenceconservation with the different WxxxE GEF family
proteins, the induction of filopodia in a WxxxE-dependent
manner raised the question of whether BtpA could also
function as a Cdc42 GEF, similar to the EPEC Map protein,
that induces filopodia around the infecting bacterium
[34,50]. Despite many attempts, including direct RhoGEF
exchange assays, we have, however, been unable to unam-
biguously show activation of Cdc42 by BtpA (not shown).
To our knowledge, formation of functional filopodia has
never been reported during Brucella infection; however,
the ectopic induction of filopodia could be a consequence
of activation of GTPases other than Cdc42, and play a
localised intracellular role during Brucella infection. How
ectopically expressed BtpA is able to induce these specific
ectopically induced actin protrusions remains a subject for
future studies.
We further analysed a role for the WxxxE motif in
microtubule dynamics. Our mutagenesis studies revealed
that the motif was not only required for induction of
filopodia, but also for interaction with microtubules.
Changes of both the Trp and the Glu residue affected
BtpA localisation. As expected, proper subcellular localisa-
tion in tubular structures (albeit with different efficiencies
for the individual variants) was required for microtubule
protection for all analysed variants (Table 1). Changes to
the Trp residue only affected the subcellular localisation
efficiency but did not alter the ability of BtpA to protect
microtubules once at the proper localization (W213F).
Interestingly, however, negative charge at the Glu position
seemed criticial for protection (the E217A variant was
localised in tubules in about 53% of the transfected cells,
yet could not protect microtubules). In addition, the motif
was also important for the ability of BtpB to protect
microtubules from degradation. Thus the WxxxE motif is
important for microtubule protection by both BtpA and
BtpB with, and negative charge in the WxxxE pocket may
be crucial for this.
In the family of WxxxE GEFs, the conserved WxxxE
motif has been shown to position a catalytic loop, that is
essential for interaction with, and selective activation of
specific Rho GTPase isoforms, exemplified by the inter-
action between Map and the β2-3 interswitch region of
Cdc42 [31,34]. Our recent resolution of the crystal
structure of the BtpA TIR domain [28] shows that the
WxxxE motif, located just adjacent of the αC helix in
TIR box 2, positions the BB loop through interaction
with a D residue (Figure 2B). Our mutagenesis results
indicate that, although the motif is important for both
colocalisation of BtpA with microtubules as well as its
ability to protect microtubules from drug-induced deg-
radation, minor differences in hydrophobic interaction
in the WxxxE pocket between the different variants,
may result in differences in positioning of the BB loop with
either flexible (E217A) or stable conformations (E217D).
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ficiency of colocalisation. Interestingly, this conform-
ation positions the G183 residue that has been shown
to be critical for interaction of BtpA with microtubules
([30] and this study), and shows that the WxxxE motif
is an important structural motif in the interaction of
BtpA with the microtubule network.
Extensive phylogenetic analysis identified 1688 TIR
containing proteins, including 483 from both pathogenic
and non-pathogenic bacteria [35]. We found that a WxxxE
motif is present in a highly conserved region of almost
all bacterial TIR proteins including the well-studied
TcpC, PdTLP, SaTLP and TlpA [53], but also in eukaryotic
TLR proteins TLR1, 2, 4, 6, and 10 and TIR adaptor
protein SARM. Whereas positioning of a catalytic loop
involved in interaction with GTPases has been de-
scribed for members of the family of WxxxE GEFs, in
bacterial TIR proteins the WxxxE motif may be involved
in positioning residues important for association with
microtubules, as shown for BtpA, or in positioning dif-
ferent loop structures.
Summarizing, our functional and structural studies
show that the Brucella Btp proteins have a structural
WxxxE motif important for their function. For several
reasons, including little overall sequence conservation
of BtpA and BtpB with the WxxxE/SopE family GEFs,
the fact that BtpB does not induce any detectable actin
rearrangements, and the conservation of the WxxxE
motif in a large family of both pro- and eukaryotic TIR
proteins, BtpA and BtpB are likely not part of the WxxxE
family of GEFs. Recently, the Bartonella type IV secretion
effector BepF, which has been shown to be involved in
activation of Rac1 and Cdc42 in a WxxxE-dependent
manner, has been suggested also likely not to represents a
WxxxE/GEF family member [54]. This raises the question
of whether there is an evolutionary advantage of the
WxxxE motif as a strong structural determinant which
may position important functional domains or catalytic
sites. Further studies, however, are needed to define a
possible role for the motif in other TIR domain containing
proteins before conclusions can be drawn about the exist-
ence of other WxxxE families. Based on the WxxxE-
dependent ability of ectopically expressed BtpA to induce
filopodia, we propose that BtpA may help gain more
insight into the frequently described cross talk between
TLR and GTPase signalling networks [55,56].
The precise role of BtpA and BtpB during Brucella
infection remains unknown. Both proteins interfere with
TLR signalling and somehow associate with microtubules,
but they seem to be independently acquired functions. We
believe that the GIs carrying btpA and btpB were acquired
when the ‘classical’ Brucella separated from the older
species (B. inopinata, Australian rodent strains) and
played a role in the development of this bacterium’s‘stealth’ approach. The distribution of the GI carrying
btpA suggests that it was lost through independent ex-
cision events several times in the evolution of the
genus (Additional file 1: Figure S1). Whereas BtpB is
present in all sequenced classical Brucella species,
BtpA is absent in for instance B. suis. Interestingly, in all
B. melitensis the tryptophan of the WxxxE motif has been
changed into arginine. It remains to be analysed whether
this rendered the protein non-functional, or whether it ac-
quired other functions.
Interestingly, in dendritic cells, intracellular TLR2 and
TLR4 have been shown to associate with microtubules
and the Golgi, and this interaction was essential for
IL-12 production in response to the intracellular pathogen
Neisseria meningitides [57]. This situation seems reminis-
cent of the interaction of BtpA with TLR4 [25] and mi-
crotubules. We hypothesize that an intracellular TLR4
signalling complex is formed in endosomes that requires
the microtubule network, and that BtpA interferes with
locally induced signalling. Our findings that BtpB has a
similar WxxxE-dependent microtubule protective role,
but does not result in the induction of filopodia after
ectopic expression, further suggests these two Brucella
virulence proteins may play partially overlapping, yet
different roles in virulence.
Materials and methods
Bacterial strains
For cloning Escherichia coli DH5α was cultured at 37°C in
Luria-Bertani broth (LB) (Invitrogen, Merck). Kanamycin
(25 μg/ml) or chloramphenicol (30 μg/ml) were added to
the media when appropriate.
Plasmids and site-directed mutagenesis
A 828 bp version of the btpA gene was cloned from B.
melitensis 16M genomic DNA (BMEI1674, Genbank
accession NP_540591 is the shorter annotated version)
using PCR (primers BglII L1674-F 5’-GAAGATCTTATGA
GTTCGTACTCTTCTAATATTG-3’, and PstIL1674-R
5’-AACTGCAGTCAGATAAGGGAATGCAGTTC-3’) and
cloned in frame with the GFP coding sequence in
eukaryotic expression plasmid pEGFP (Clontech) using
standard protocols, resulting in plasmid pIN271.
A 978 version of the btpB gene was cloned from
B. suis genomic DNA (BR0735, Genbank accession
number AAN29664 is the shorter annotated version)
using PCR (primers BglII 735-F 5’-GAAGATCTTATG
ACATCTAGTCGCGACACG-3’, and PstI 735-R 5’-
AACTGCAGCTAGGTGATGAGGGCGACG-3’) and
cloned in frame with the GFP coding sequence in
pEGFP resulting in plasmid pIN292. We amplified a
longer version of btpB, which was recently also shown
to complement a B. abortus btpB mutant in the control of
NF-κB translocation into the nucleus [17].
Table 2 Strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source
E. coli DH5α DH5α F − 80lacZΔM15 Δ(lacZYA-argF)U169 endA1
recA1 hsdR17 (rK −mK+) supE44 thi-1ΔgyrA96 relA1
pEGFP-C3 plasmid containing an enhanced GFP expression unit
under control of the CMV promoter, Kmr
Clontech
pIN271 pEGFP derived plasmid containing GFP-btpA
expression unit, Kmr
This Study
pIN275 pIN271-derivative carrying btpA W213A This Study
pIN269 pIN271-derivative carrying btpA W213S This Study
pIN274 pIN271-derivative carrying btpA W213F This Study
pIN270 pIN271-derivative carrying btpA E217A This Study
pIN277 pIN271-derivative carrying btpA E217D This Study
pIN262 pIN271-derivative carrying btpA I262S This Study
pIN283 pIN271-derivative carrying btpA G183A This Study
pIN292 pIN271-derivative carrying btpB This Study
pIN293 pIN271-derivative carrying btpB W263S This Study
pIN294 pIN271-derivative carrying btpB E267A This Study
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done using the QuickChange Site-Directed Mutagenesis
kit (Stratagene) following manufacturer’s instructions, using
pIN271 as a template with the following mutagenic primers
for btpA (changed codons for Trp (TGG) and Glu (GAA)






CTGAC-3’), I226S (5’- CTGACGGCAATGGAAAGTGG
CGGACAGACGC-3’), G183A (5’- CATATACGTTGAA
GGTCGCTGACAGCCTTCGGCG-3’), and btpB (pIN292
as a template): W263S (5’- CTATCAGCGAAAAGACTCG
TGCGGCGTCG-3’) and E267A (5’- CTGGTGCGGCGT
CGCGTTCCGCGCGATTCG-3’). Constructs were verified
by DNA sequencing (Eurofins MWG operon, Germany).
Table 2 summarizes the plasmids used in this study.
Cell culture, transfection, immunocytochemistry, and
fluorescence microscopy
HeLa cells were grown in RPMI 1640 (Gibco) supple-
mented with heat-inactivated 10% fetal bovine serum
(FBS, Lonza, Switzerland). Transfections were performed
using Lipofectamine 2000 (Invitrogen). For immuno
fluorescence studies, cells were seeded on coverslips
(BD Bioscience) and cultured overnight in 12-well dishes.
Cells were transfected and, after 16–20 hours, treated with
nocodazole (Sigma M1404) at a concentration of 1 μg/ml
for 30 min if desired. Cells were fixed with 4% PFA, and
processed for immunocytochemistry. Monoclonal mouse
anti-β-tubulin (Sigma Aldrich, T4026), mouse anti-FK2(Enzo Life science, BML-PW8810), Texas Red anti-
mouse (Vector Laboratories, TI-2000), Rhodamin phalloidin
(Invitrogen R415), Rabbit anti-BtpA (a gift fromMarty Roop,
East Carolina University, Greenville), FITC anti-rabbit
(Vector Laboratories, FI-2000) were used for immune
labelling. Immuno fluorescence microscopy was performed
using a LEICA DM/IRB microscope using filter sets L5
(band pass (BP) 480/40; Beam splitter (BS) 505; emission
BP527/30) and N2.1 (515–560; BS 580; emission long pass
(LP) 590), respectively. For imaging we used a Coolsnap fx
(Roper Scientifique) and MetaVue software, and images
were further processed using Adobe Photoshop. Confocal
analysis was performed at the RIO imaging platform in
Montpellier, with a Biorad MRC1024 confocal microscope.Bio informatic analysis
Brucella genomes were obtained and compared on the
PATRIC website [33]. Sequence alignments were per-
formed using T-Coffee analysis, and further analysed
using Jalview. Structural figures were generated with
Pymol (www.pymol.org).Additional files
Additional file 1: Figure S1. Evolutionary tree of Brucella species and
distribution of BtpA and BtpB proteins. The alignment was made in Patric
and the tree was optimized using Mega Software. btpA and btpB genes
are highly conserved throughout the genus. We found only four
variations in 407 sequences (showing 47 species). All B. melitensis strains
carry a single amino acid change (leading to A163V), while three strains
carry a variation in R167H (B. ovis), G200D (B. suis ATCC23445) or V182G
(B. neotomae). BtpB is also highly conserved, with only two amino acids
that show variation. The Trp residue, as part of a WxxxE motif, in BtpB
was replaced by an Arg residue in B. melitensis BtpB (W263R).
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http://www.biosignaling.com/content/12/1/53Additional file 2: Figure S2. Confocal imaging of BtpA in HeLa cells
shows tubular localisation at cell periphery. HeLa cells were transiently
transfected with a plasmid encoding GFP-BtpA, fixed after 16 h and
analysed by confocal microscopy. The coloured image (green) shows the
merged stack images of 14 Z-slices, the other images show the individual
Z-images (1 μm depth) of HeLa cells expressing GFP-BtpA. Bar, 25 μm.
Additional file 3: Figure S3. Ectopic expression of BtpA in HeLa cells
shows colocalisation with microtubules HeLa cells were transiently
transfected with a plasmid expressing GFP-BtpA. At 16 h cells were fixed
and processed for immuno labelling with mouse anti β-tubulin antibody,
detected with anti-mouse Texas Red to visualize microtubules
(red fluorescence). The large image shows a merged image of 6 Z-Stack
confocal images (1 μm depth) of cells with microtubules (in red) and
GFP-BtpA in one of the cells. Arrow heads indicate colocalisation of
GFP-BtpA with the microtubule network (yellow), at the periphery of the
cell. The other images represent the individual Z-stack images. Scale bar,
25 μm. Data are representative of 3 or more independent experiments.
Additional file 4: Figure S4. Expression phenotypes of GFP-BtpB in
HeLa cells. HeLa cells were transiently transfected with a plasmid expressing
GFP-BtpB. At 16 h cells were fixed, processed, and analysed using fluorescence
microscopy. The individual images show the different observed expression
patterns ranging from a diffuse signal, to cells with a diffuse fluorescent
signal as well as accumulation of BtpB in punctae, heterogeneous in size
and number. Scale bar, 25 μm.
Additional file 5: Figure S5. Colocalisation of BtpB and conjugated
ubiquitin. HeLa cells were transiently transfected with a plasmid
expressing GFP-BtpB. At 16 h cells were fixed and processed for immune
labelling with mAb FK2, which detects mono- and poly conjugated
ubiquitin, and labelled with anti-mouse Texas Red for fluorescence
detection. A. Confocal images showing stacks of overlay and individual
GFP-BtpB and FK2 images. Scale bar, 10 μm. B. Two fluorescence images
(red and green filters) showing colocalisation of BtpB and FK2, also at the
intercellular bridge in late cytokinesis (arrow, and boxed areas). Scale bar,
25 μm C. Image showing transfected and non-transfected cells with and
without FK2 positive foci. Cells indicated with numbers in the overlay panel
(on the right) are enlarged below as individual green and red fluorescent
images. Scale bar, 25 μm. 1, 2. Transfected cells with a punctate pattern for
BtpB, colocalising with FK2. FK2 positive, BtpB negative foci are also
observed. 3, 4: Non-transfected, FK2 positive foci. 5. Transfected, no visible
BtpB punctae, FK2 positive.
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